Immune Checkpoint Modulators: An Emerging Antiglioma Armamentarium

Immune checkpoints have come to the forefront of cancer therapies as a powerful and promising strategy to stimulate antitumor T cell activity. Results from recent preclinical and clinical studies demonstrate how checkpoint inhibition can be utilized to prevent tumor immune evasion and both local and...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Eileen S., Kim, Jennifer E., Patel, Mira A., Mangraviti, Antonella, Ruzevick, Jacob, Lim, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4736366/
https://www.ncbi.nlm.nih.gov/pubmed/26881264
http://dx.doi.org/10.1155/2016/4683607

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4736366/
https://www.ncbi.nlm.nih.gov/pubmed/26881264
http://dx.doi.org/10.1155/2016/4683607

Ejemplares similares